Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GHNASDAQ:OPCHNASDAQ:RDNTNASDAQ:WGS On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGHGuardant Health$38.00+2.6%$43.39$20.14▼$52.92$4.59B1.492.15 million shs1.37 million shsOPCHOption Care Health$31.41-1.9%$32.99$21.39▼$35.53$5.14B0.761.86 million shs836,498 shsRDNTRadNet$56.61-0.3%$52.81$45.00▼$93.65$4.25B1.46687,151 shs454,156 shsWGSGeneDx$71.60+6.3%$84.79$19.54▼$117.75$2.04B1.96768,557 shs660,629 shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGHGuardant Health0.00%-6.57%-19.85%-11.36%+68.81%OPCHOption Care Health0.00%-5.48%-2.39%-1.84%+8.20%RDNTRadNet0.00%-7.41%+12.21%-4.81%-2.51%WGSGeneDx0.00%+4.82%-34.55%-25.28%+258.18%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGHGuardant Health4.6421 of 5 stars4.52.00.04.34.02.50.6OPCHOption Care Health4.3692 of 5 stars2.45.00.04.23.82.51.3RDNTRadNet3.414 of 5 stars2.71.00.04.63.52.50.0WGSGeneDx3.2964 of 5 stars2.42.00.00.04.15.01.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGHGuardant Health 3.05Buy$52.3237.68% UpsideOPCHOption Care Health 2.88Moderate Buy$35.5013.02% UpsideRDNTRadNet 3.40Buy$69.7523.21% UpsideWGSGeneDx 2.75Moderate Buy$86.7521.16% UpsideCurrent Analyst Ratings BreakdownLatest WGS, OPCH, GH, and RDNT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/15/2025WGSGeneDxGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$88.005/9/2025WGSGeneDxJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$80.005/6/2025GHGuardant HealthPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$50.00 ➝ $60.005/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform5/5/2025GHGuardant HealthScotiabankSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetSector Outperform ➝ Sector Outperform$52.00 ➝ $57.005/1/2025GHGuardant HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$60.00 ➝ $65.005/1/2025GHGuardant HealthTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$56.00 ➝ $60.005/1/2025GHGuardant HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$55.00 ➝ $60.005/1/2025GHGuardant HealthStifel NicolausSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$53.00 ➝ $60.005/1/2025GHGuardant HealthUBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$65.00 ➝ $70.005/1/2025WGSGeneDxTD SecuritiesSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$135.00 ➝ $110.00(Data available from 5/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGHGuardant Health$774.00M6.08N/AN/A$1.34 per share28.36OPCHOption Care Health$5.19B0.99$1.83 per share17.19$8.03 per share3.91RDNTRadNet$1.87B2.27$3.01 per share18.81$11.79 per share4.80WGSGeneDx$330.14M6.19N/AN/A$8.78 per share8.15Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGHGuardant Health-$479.45M-$3.39N/AN/AN/A-59.05%-19,157.20%-25.96%8/6/2025 (Estimated)OPCHOption Care Health$267.09M$1.2426.3924.932.304.37%15.30%6.57%7/30/2025 (Estimated)RDNTRadNet$3.04M-$0.43N/A106.81N/A-0.25%4.29%1.45%8/5/2025 (Estimated)WGSGeneDx-$175.77M-$1.41N/A34.26N/A-17.12%3.33%1.69%7/29/2025 (Estimated)Latest WGS, OPCH, GH, and RDNT EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/30/2025Q1 2025GHGuardant Health-$0.57-$0.49+$0.08-$0.77$189.91 million$203.47 million4/30/2025Q1 2025WGSGeneDx$0.11$0.28+$0.17-$0.23$79.90 million$87.12 million4/29/2025Q1 2025OPCHOption Care Health$0.36$0.40+$0.04$0.28$1.26 billion$1.33 billion2/27/2025Q4 2024RDNTRadNet$0.21$0.22+$0.01$0.07$459.42 million$477.10 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGHGuardant HealthN/AN/AN/AN/AN/AOPCHOption Care HealthN/AN/AN/AN/AN/ARDNTRadNetN/AN/AN/AN/AN/AWGSGeneDxN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGHGuardant HealthN/A6.225.85OPCHOption Care Health0.771.731.32RDNTRadNet0.892.162.16WGSGeneDx0.252.402.27Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGHGuardant Health92.60%OPCHOption Care Health98.05%RDNTRadNet77.90%WGSGeneDx61.72%Insider OwnershipCompanyInsider OwnershipGHGuardant Health6.10%OPCHOption Care Health0.64%RDNTRadNet5.12%WGSGeneDx29.60%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGHGuardant Health1,790123.89 million116.76 millionNot OptionableOPCHOption Care Health5,600163.75 million169.09 millionOptionableRDNTRadNet8,97075.03 million70.24 millionOptionableWGSGeneDx1,20028.53 million19.97 millionOptionableWGS, OPCH, GH, and RDNT HeadlinesRecent News About These CompaniesPalisades Investment Partners LLC Acquires New Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 24 at 6:53 AM | marketbeat.com61,710 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Purchased by Castleark Management LLCMay 24 at 6:05 AM | marketbeat.comPharVision Advisers LLC Buys Shares of 3,910 GeneDx Holdings Corp. (NASDAQ:WGS)May 24 at 5:32 AM | marketbeat.comGeneDx Publishes Pioneering Vision for Applying AI to Genomics to Improve and Expedite Diagnosis of Genetic Disease at ScaleMay 22 at 9:30 PM | finance.yahoo.comGeneDx to Participate in Upcoming Investor ConferencesMay 22 at 4:05 PM | businesswire.comPoint72 Asset Management L.P. Sells 230,583 Shares of GeneDx Holdings Corp. (NASDAQ:WGS)May 22 at 4:42 AM | marketbeat.comSoleus Capital Management L.P. Invests $307,000 in GeneDx Holdings Corp. (NASDAQ:WGS)May 21, 2025 | marketbeat.comSilvercrest Asset Management Group LLC Takes Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 21, 2025 | marketbeat.comGeneDx: Strong Fundamentals Intact As Market Misreads Test Volume DipMay 20, 2025 | seekingalpha.com13,100 Shares in GeneDx Holdings Corp. (NASDAQ:WGS) Bought by Polar Asset Management Partners Inc.May 20, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Shares Bought by Summit Partners Public Asset Management LLCMay 19, 2025 | marketbeat.comRedwood Investment Management LLC Makes New Investment in GeneDx Holdings Corp. (NASDAQ:WGS)May 19, 2025 | marketbeat.comEnsign Peak Advisors Inc Acquires Shares of 26,900 GeneDx Holdings Corp. (NASDAQ:WGS)May 18, 2025 | marketbeat.comGeneDx Holdings Corp. (NASDAQ:WGS) Holdings Lifted by Northern Trust CorpMay 18, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Trading Up 5.8% - Here's What HappenedMay 18, 2025 | americanbankingnews.comDimensional Fund Advisors LP Takes $1.08 Million Position in GeneDx Holdings Corp. (NASDAQ:WGS)May 18, 2025 | marketbeat.comGeneDx (NASDAQ:WGS) Earns Buy Rating from Analysts at GuggenheimMay 18, 2025 | americanbankingnews.comBNP Paribas Financial Markets Purchases Shares of 56,588 GeneDx Holdings Corp. (NASDAQ:WGS)May 17, 2025 | marketbeat.comTreehouse Foods, GeneDx Holdings See Activist ActionMay 16, 2025 | msn.comPanoramic Capital LLC Purchases Shares of 51,294 GeneDx Holdings Corp. (NASDAQ:WGS)May 16, 2025 | marketbeat.comNia Impact Advisors LLC Invests $1.48 Million in GeneDx Holdings Corp. (NASDAQ:WGS)May 16, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesArcher Aviation Gets Analyst Target Upgrade: Time to Load Up?By Jeffrey Neal Johnson | April 25, 2025View Archer Aviation Gets Analyst Target Upgrade: Time to Load Up?NVIDIA Stock Surges on Bullish News: How High Could It Climb?By Thomas Hughes | May 13, 2025View NVIDIA Stock Surges on Bullish News: How High Could It Climb?Super Micro Computer Stock Clears New Path Higher on Saudi OrdersBy Gabriel Osorio-Mazilli | May 22, 2025View Super Micro Computer Stock Clears New Path Higher on Saudi OrdersTop 5 Stocks Hedge Funds Are Buying Right NowBy Ryan Hasson | May 20, 2025View Top 5 Stocks Hedge Funds Are Buying Right NowPalantir’s Latest Deal Could Put a Freeze on Its Stock PriceBy Chris Markoch | May 12, 2025View Palantir’s Latest Deal Could Put a Freeze on Its Stock PriceWGS, OPCH, GH, and RDNT Company DescriptionsGuardant Health NASDAQ:GH$38.00 +0.95 (+2.56%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$38.40 +0.40 (+1.05%) As of 05/23/2025 07:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research. The company was incorporated in 2011 and is headquartered in Palo Alto, California.Option Care Health NASDAQ:OPCH$31.41 -0.62 (-1.94%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$31.00 -0.41 (-1.32%) As of 05/23/2025 04:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.RadNet NASDAQ:RDNT$56.61 -0.16 (-0.28%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$57.78 +1.17 (+2.06%) As of 05/23/2025 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; offers picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as AI solutions for prostate cancer screening. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.GeneDx NASDAQ:WGS$71.60 +4.27 (+6.34%) Closing price 05/23/2025 04:00 PM EasternExtended Trading$70.94 -0.66 (-0.92%) As of 05/23/2025 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 05/19 - 05/23 Trade Desk Silences Critics; Recovery Looks Poised to Continue Booz Allen Hamilton Earnings: 3 Bullish Signals for BAH Stock Turbulence for Joby Shares: What's Behind the Recent Dip? Pfizer's 7.5% Dividend: Income Haven or House of Cards? TJX Stock Price Stumble Is Your Chance to Pick Up a Bargain These ETFs Provide Easy Exposure to Growing International Markets Advance Auto Parts Jumps on Surprise Earnings Beat Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
